Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spotlight on Sotorasib (AMG 510) for KRASG12C Positive Non-Small Cell Lung Cancer
Shannon Zhang, Misako Nagasaka
Lung Cancer Targets and Therapy (2021) Vol. Volume 12, pp. 115-122
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Molecular targeted therapy for anticancer treatment
Hye‐Young Min, Ho‐Young Lee
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 10, pp. 1670-1694
Open Access | Times Cited: 240
Drug resistance mechanisms and progress in the treatment of EGFR‑mutated lung adenocarcinoma (Review)
Ruizhu Sun, Zhansheng Hou, Yankui Zhang, et al.
Oncology Letters (2022) Vol. 24, Iss. 5
Open Access | Times Cited: 41
Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors
G. Leslie Burnett, Yu Chi Yang, James B. Aggen, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 149-169
Open Access | Times Cited: 30
RAS‐targeted cancer therapy: Advances in drugging specific mutations
Cen Liu, Danyang Ye, Hongliu Yang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 18
Targeting KRASG12C-Mutated Advanced Colorectal Cancer: Research and Clinical Developments
Jingran Ji, Chongkai Wang, Marwan Fakih
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 747-756
Open Access | Times Cited: 26
Covalent-Allosteric Inhibitors: Do We Get the Best of Both Worlds?
Hui Tao, Bo Yang, Atena Farhangian, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Small molecules for Kirsten rat sarcoma viral oncogene homolog mutant cancers: Past, present, and future
Peiliang Dong, Jiating Ni, Xinyue Zheng, et al.
European Journal of Pharmacology (2025), pp. 177428-177428
Closed Access
Intracranial Activity of Sotorasib in KRAS G12C -Mutated Recurrent Glioblastoma
Katherine P. Morgan, Allison Carroll, Yasmeen Rauf, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
Sotorasib as first-line therapy in patients with advanced non-small cell lung cancer with KRAS gene mutations combined with brain metastases: a case report
Xianglong Jia, Meng Liu, Zhiqiang Cheng
AME Case Reports (2024) Vol. 8, pp. 48-48
Open Access | Times Cited: 2
The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors
Samuel A. Kareff, Asaad Trabolsi, Harris B. Krause, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1572-1572
Open Access | Times Cited: 2
p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications
Dixan A. Benitez, Guadalupe Cumplido-Laso, Marcos Olivera-Gómez, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1453-1453
Open Access | Times Cited: 2
Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis
Caroline-Claudia Erhart, Marco Cefalì, Dylan Mangan, et al.
Schweizerische medizinische Wochenschrift (2024) Vol. 154, Iss. 7, pp. 3695-3695
Open Access | Times Cited: 2
Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
Christophe Bontoux, Véronique Hofman, Patrick Brest, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1628-1628
Open Access | Times Cited: 12
CodeBreak 200: Sotorasib Has Not Broken the KRASG12C Enigma Code
Shannon Zhang, Alexandria TM Lee, Misako Nagasaka
Lung Cancer Targets and Therapy (2023) Vol. Volume 14, pp. 27-30
Open Access | Times Cited: 6
Targeted Therapies for Perihilar Cholangiocarcinoma
Simon Gray, Ángela Lamarca, Julien Edeline, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1789-1789
Open Access | Times Cited: 9
Unveiling hidden connections in omics data via pyPARAGON: an integrative hybrid approach for disease network construction
M. Kaan Arici, Nurcan Tunçbağ
Briefings in Bioinformatics (2024) Vol. 25, Iss. 5
Open Access | Times Cited: 1
A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition
Pedro Barrios‐Bernal, José Lucio-Lozada, Maritza Ramos-Ramírez, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4331-4331
Open Access | Times Cited: 4
Adagrasib: a novel inhibitor for KRASG12C-mutated non-small-cell lung cancer
Matthew Z. Guo, Kristen A. Marrone, Alexander I. Spira, et al.
Future Oncology (2023) Vol. 19, Iss. 15, pp. 1037-1051
Closed Access | Times Cited: 4
Long term survival achieved through combination of almonertinib and pyrotinib in EGFR-mutant/HER2-amplified advanced NSCLC patient: a case report and literature review
Xin Pan, Xiao Zhou
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
An updated overview of K-RAS G12C inhibitors in advanced stage non-small cell lung cancer
Ateş Kutay Tenekeci, A. Unal, Furkan Ceylan, et al.
Future Oncology (2024) Vol. 20, Iss. 37, pp. 3019-3038
Closed Access | Times Cited: 1
Sotorasib: First Approved KRAS Mutation Inhibitor for the Treatment of Non-small Cell Lung Cancer
Surya K. De
Current Medicinal Chemistry (2022) Vol. 30, Iss. 9, pp. 1000-1002
Closed Access | Times Cited: 4
Fc Epsilon RI–Neuroimmune Interplay in Pruritus Triggered by Particulate Matter in Atopic Dermatitis Patients
Dina Isaifan, Sérgio Crovella, Lama Soubra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11851-11851
Open Access | Times Cited: 2
Runx3 Restoration Regresses K-Ras-Activated Mouse Lung Cancers and Inhibits Recurrence
Ja-Yeol Lee, Jung-Won Lee, Tae-Geun Park, et al.
Cells (2023) Vol. 12, Iss. 20, pp. 2438-2438
Open Access | Times Cited: 2
Targeted Therapies for Kirsten Rat Sarcoma (KRAS) G12C Mutant Metastatic Non-Small-Cell Lung Cancers
Cian O’Leary, Grace Murphy, Yong Yeung, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5582-5582
Open Access | Times Cited: 2
Successful first-line treatment of simultaneous multiple primary malignancies of lung adenocarcinoma and renal clear cell carcinoma: A case report
Xiaojun Ye, Xiangliang Liu, Na Yin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top